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Abstract. Glioblastoma is the most common primary brain
tumor, characterized by its resistance to treatments. To define
efficient therapy, the origin of tumor-forming cells needs
to be elucidated in order to search for new therapeutic
pathways. The objective of this study was to determine the
different cell populations constituting a human glioblastoma
cell line, U-87 MG and their sensitivity to apoptosis induced
through the activation of Fas, a membranous death receptor.
By a cell sorting method, the sedimentation field flow
fractionation, two major cell subpopulations were identified,
a most differentiated cell fraction, containing large and
adherent cells, sensitive to Fas-induced apoptosis and another
one, characterized by small cells forming aggregates,
expressing CD133, a marker of stem cells and more resistant
to Fas-activated apoptosis. By using a selective method of
culture, adapted for neural stem cell cultures, we have
verified that the U-87 MG cell line contained cancer stem
cells similar to the immature ones obtained by the cell
sorting method. Interestingly, while these tumor stem cells,
expressing CD133, were resistant to Fas-induced apoptosis,
monomeric form of Fas protein was detected predominantly
in these cells. In contrast, the most mature cells, responsive
to Fas-activated apoptosis, collected in another cell fraction,
contained oligomeric aggregates of Fas protein, a pre-signalling
form of the Fas receptor, essential for the initiation of apoptosis
through its activation. These results suggest that these immature
stem cells in glioma could be an important factor of resistance
to chemotherapy requiring apoptosis through Fas signalling
system. Indeed, future strategies of treatment, inducing
differentiation of these stem cells need to be considered to
enhance therapeutic efficiency. 
Introduction
Glioblastoma multiform is the most common malignant
primary brain tumor in adults and it is among the most lethal
of all cancers (1). Gliomas are particularly invasive tumors
and their prognosis remain very poor despite surgery-
radio- and chemotherapy (2), with a mean survival <1 year.
Glioma cells are characterized by their resistance to induce
apoptosis and by some features of immature cells. The neural
stem-cell model for the origins of gliomas shed light on their
heterogeneity (3). Recently, self-renewing, multipotent cells
expressing the CD133 surface cell-marker were isolated from
human gliomas and transplanted into adult mouse brain, where
they recapitulated the parents tumor's histology (4). These
findings suggest that gliomas are both initiated and maintained
by a small fraction of cancerous neural stem-cells. Therefore,
CD133+ cells are obviously considered as a potentially relevant
target tumor cell subpopulation for therapy in the context of
the whole tumor mass (4).
Apoptosis plays an important role in regulation of cellular
activities in eukaryotes (5), and its deregulation contributes
to the pathogenesis of several diseases (6). The Fas receptor
(APO-1, CD95) is a member of the tumor necrosis factor
(TNF)/nerve growth factor death receptor superfamily and its
monomeric form is a 45-52-kDa type I transmembrane protein
(7). Fas extracellular domain contains three cystein-rich
repeats and two of them bind the Fas natural ligand, FasL (8).
Their disruption leads to the loss of ligand binding and
effector's signalling (9). It was first demonstrated that following
engagement with FasL or agonistic anti-Fas monoclonal
antibody (mAb), Fas monomers trimerize, which leads to the
recruitment of the intracellular death domain and to a down-
stream activation of the death-inducing signalling complex
(10). Subsequently, the adaptor protein Fas-associated death
domain interacts with Fas cytoplasmic death domain and
recruits procaspase-8, which can thereby self-activate.
Cleavage of downstream substrates by caspase-8 rapidly
triggers cell death (11). More recently, Fas trimerization was
shown to occur also without FasL binding. This preassembly
of Fas monomers, named the pre-ligand assembly domain
is required for the subsequent clustering of Fas receptor after
FasL ligation (12). Fas polymerization leads to sodium dodecyl
sulfate (SDS) - stable high molecular weight aggregates that
are easily detected by SDS-polyacrylamide gel electrophoresis
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(SDS-PAGE) (13). Indeed, apoptosis induced through Fas
pathway is depending on the pre-association of Fas receptor
onto the cell membrane. This pre-association is potentially
regulated by phosphorylation of extra cellular part of receptor,
leading to the inhibition of Fas pre-association (14). However,
it is worth noting that other non-apoptotic functions were
associated to Fas/FasL interaction such as neuritogenesis
of dorsal root ganglia (15) or survival and growth of some
tumor cell lines (16). Hence, the resistance of tumor cells to
Fas-mediated apoptosis needs to be evaluated in the choice of
cytotoxic drugs that kill drug-sensitive cells by inducing the
Fas system (17). It has been reported that some glioma cells
express both Fas (18) and FasL (19) but although expressing
substantial levels of Fas, these cells are generally resistant to
cell death induced by FasL treatment (18).
To define the degree of resistance to Fas-activated
apoptosis in glioblastoma and its relationship to the immature
stage of these cells, this report focused on the isolation of
immature and tumor neural stem-cells contained in a human
glioma cell line, U-87 MG and their responsiveness to Fas-
induced apoptosis. Two methods were used to obtain immature
and tumor cell stems, a cell-sorting method, the sedimentation
field flow fractionation (SdFFF) able to separate immature
and differentiated cells as previously demonstrated (20-22)
and a longest selection method based on the growth properties
of tumor stem cells in a defined culture medium (23). 
This study showed that Fas activation by an agonistic
monoclonal antibody (mAb) induced apoptosis of the most
differentiated cells. Consequently, by using the properties of
SdFFF, we demonstrated that the functional effects of Fas
activation in U-87 MG cells depended on the differentiation
stage of these cells. Indeed, the subpopulation of tumor
neural stem-cells, expressing CD133 marker which was
isolated from this cell line by SdFFF or obtained by selective
culture medium, exhibited a significant resistance to Fas-
induced apoptosis, compared to the most differentiated cells
isolated in another SdFFF fraction. These finding were
assessed also on tumor stem cells cultured in defined medium.
Interestingly, these immature tumor cells were resistant to
Fas-induced apoptosis. Therefore, this subpopulation of tumor
cells could be implicated in the resistance of glioblastoma
to conventional treatments, potentially unable to induce
apoptosis of these immature cells, explaining the relapse
occurring after treatment. Indeed, it seems of major interest
to identify immature and cancer stem cells in order to
evaluate their sensitivity to new molecules in therapeutic
research pathways.
Materials and methods
Cell line and cell culture. The U-87 MG human glioblastoma
cell line was obtained from American Type Culture Collection
(ATCC, LGC Promochem SARL, Molsheim, France). The
cells were maintained in MEM with Earle's salts (Gibco
BRL, Life Technologies, Paisley, UK) supplemented with
10% decomplemented foetal calf serum (FCS), 1.5 g/l
sodium bicarbonate, 1% non-essential amino acids, sodium
pyruvate (2 mM), penicillin (50 U/ml), streptomycin (50 U/ml),
L-glutamine (2 mM) and fungizone (0.1%) (Gibco BRL).
Cells were grown in 25 cm2 flask (Nunc Fisher Bioblock
Scientific, Illkrich, France) at 37˚C in a humidified 5% CO2-
95% air incubator. 
Freshly versenized, 106 cells were seeded onto flasks
(25 cm2) for 3 days before SdFFF analysis. Cell viability was
determined by trypan-blue exclusion: cell concentration was
adjusted to 2.5x106 cells/ml in phosphate buffered saline (PBS)
before SdFFF analysis. After SdFFF sorting, control and
eluted cells were seeded (105 cells/well) in 24-well-plates
(Nunc, Fisher Bioblock Scientific). For light microscopy,
cultured cells were examined under phase-contrast microscopy
(magnification x400). Photos were taken with a Nikon camera
(Champigny/Marne, France).
To obtain neurosphere-like cells, U-87 MG cells were
cultured in serum-free medium (23) containing DMEM/F12,
30% glucose (Sigma Aldrich, Saint-Quentin-Fallavier, France),
1 M HEPES buffer (Sigma), progesterone (Sigma), putrescine
(Sigma), B27 growth supplement (Invitrogen), 20 ng/ml EGF
(Sigma), 20 ng/ml FGF (Sigma), Insulin-Transferrin-Sodium
Selenite Supplement (Roche Diagnostics, Meylan, France)
and heparin (Sigma). After a 4-day culture, U-87 MG formed
primary neurospheres. Primary neurospheres were dissociated
and cells were seeded to form secondary neurospheres, cultured
during 48 h before immunostaining and apoptosis studies.
Immunocytofluorescence staining. For immunofluorescence
studies, cells were grown on glass coverslips in a 24-well plate.
After two washes in PBS, the cells were fixed for 15 min in
4% paraformaldehyde in PBS, washed twice in PBS and per-
meabilized 30 min with a solution of Triton X-100 0.1%-PBS
at room temperature. Then, cells were washed twice in PBS
and incubated in PBS-4% bovine serum albumin (BSA) for
2 h at room temperature. Cells were incubated overnight at
4˚C with primary antibodies (Abs) diluted in PBS-BSA.
The following antibodies were used: a mouse anti-vimentin
monoclonal Ab (mAb) (clone RV202, 1:200 dilution, Santa
Cruz Biotechnology, Heidelberg, Germany), a rabbit polyclonal
anti-CD133 (clone RB 1784, 1:100 dilution, Abgent, San
Diego, CA), or anti-glial fibrillary protein (GFAP) (1:500
dilution, DakoCytomation, Trappes, France). Negative controls
were done with cells incubated with irrelevant normal rabbit
or mouse IgG (Santa Cruz).
Cells were washed twice in PBS and incubated with 1 μg/ml
Alexafluor 488- or 596- conjugated anti-mouse or anti-rabbit
immunoglobulin (Ig) Abs (Invitrogen) for 120 min at 4˚C.
After two further washes in PBS, cells were mounted in
glycerol-gelatin medium (Sigma-Aldrich) and fluorescence
was analyzed using a Leica DMRX microscope (Leica Micro-
systems, Rueil-Malmaison, France). 
Flow cytometry analysis. Cells were harvested, washed
with PBS, fixed and permeabilized with IntraStain (Dako-
Cytomation), before staining with the Abs recognizing
vimentin, CD133 or GFAP purchased as above. Fas expression
was analyzed with a rabbit anti-Fas polyclonal Ab (clone
C-20, Santa Cruz) specific of the intracellular part of the
receptor, at a dilution of 1:100 in PBS for 30 min at 4˚C, and
revealed by Fluorescein isothiocyanate (FITC)-conjugated
anti-rabbit Ig (Santa Cruz) at a dilution of 1:200 in PBS for
30 min at 4˚C before analysis by flow cytometry (Beckman
FC 500, Beckman Coulter Villepinte, France). Moreover
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phycoerythrin (PE)-conjugated anti-Fas mAb (clone IM1739,
Beckman Coulter) and PE-conjugated anti-neural cell adhesion
molecule (N-CAM) mAb (clone NKH1 RD1, Beckman
Coulter) were used at a dilution of 1:100 in PBS for 30 min
at 4˚C. Cells stained with either rabbit or mouse isotypic
irrelevant Ig (Santa Cruz) were used as controls to determine
background and positivity thresholds. Ten thousand cells
were acquired; data were analyzed using the computer program
WinMDI (version 2.8).
Apoptosis quantification. After a 48-h culture, cells were
treated with 40 ng/ml of anti-Fas agonistic mAb (Fas clone
7C11 sodium azide-free, Beckman Coulter) (24). After a
24-h treatment, apoptosis was analyzed by two methods.
One method, measuring cytoplasmic soluble mono- and
oligo-nucleosomes released during apoptosis, was based
on enzyme-linked immunosorbent assay (ELISA) using
antibodies directed against DNA and histones (Cell Death
Detection ELISAPLUS, Roche Diagnostics, Meylan, France)
according to the manufacturer's protocol to quantify apoptotic
index as previously described (25). 
Another method used Annexin-V-FITC staining (Beckman
Coulter) which indicates phosphatidylserin translocation to
the cell surface in apoptotic cells. This staining was associated
to those of propidium iodide (PI, red fluorescence), a DNA-
intercalating agent that reflected the membranous permeability
as observed during necrosis or at the latter stage of apoptosis.
Cells were analyzed by flow cytometry (Beckman FC 500).
SdFFF device and cell elution conditions. SdFFF separation
device used in this study derived from those previously
described and schematized (26,27). The apparatus consists
of two 938x40x2 mm polystyrene plates, separated by a
mylar® spacer in which the channel was curved. Channel
dimensions were 818x12x0.175 mm with two 50 mm V-shaped
ends. The measured total void volume (channel volume +
connecting tubing + injection and detection device) was
1792±2.00 μl. Void volume was calculated after injection
and elution time determination of a non-retained compound
(0.10 g/l of benzoic acid, UV detection at 254 nm, n=6). The
channel rotor axis distance was measured at r=14.82 cm. A
Waters 590 programmable HPLC pump (Waters Associates,
Milford, MA) was used to pump the sterile mobile phase.
The elution signal was recorded at 254 nm by means of a
M1111 (100 mV input) acquisition device (Keithley,
Metrabyte, Tauton, MA) operated at 4 Hz and connected to a
Macintosh computer. The optimal elution conditions were
determined experimentally and were: flow injection through
the accumulation wall of 100 μl of U-87 MG cell suspension
(2.5x106 cells/ml); flow rate: 0.80 ml/min; mobile phase: sterile
PBS, pH 7.4 (Gibco BRL); external multi-gravitational field
strength: 24.50±0.05 g and spectrophotometer detection at
Ï = 254 nm (Waters 486 Tunable Absorbance Detector,
Waters Associates).
For this device, sedimentation fields were expressed in
units of gravity, 1 g = 980 cm/s2, and calculated as previously
described (27). A M71B4 Carpanelli engine associated
with a pilot unit Mininvert 370 (Richard Systems, Les Ullis,
France), controlled the rotating speed of the centrifuge
basket. Sample injections were done by means of a Rheodyne®
7125i chromatographic injector (Rheodyne, Cotati, CA,
USA). Cleaning and decontamination procedures have been
described in a previous report (28). 
For this population, fractions were collected and designated
as follow: TP, the total peak; and PF, peak fractions. For cell
sorting, 4 fractions were collected: TP (2 min 20 sec to 8 min
00 sec) and -PF1 (2 min 20 sec to 4 min 15 sec), PF2 (4 min
20 sec to 6 min 00 sec) and PF3 (6 min 10 sec to 8 min 00 sec).
To obtain a sufficient quantity of cells for cultures, and further
analyses successive SdFFF cumulative fraction collections
were performed (10 to 15).
Coulter counter. A 256 channels Multisizer II Coulter Counter
(Beckman Coulter) was used to determine the mean cell
population diameter. Crude population or SdFFF collected
fractions were diluted in Isoton® to a final volume of 15 ml.
The counting conditions were 500 μl sample volume,
cumulating three successive assays. Results are displayed as
the mean ± SEM for three different experiments.
Western blotting. After SdFFF analysis cells were lysed in
RIPA lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl,
1% deoxycholate, 1% Nonidet P-40, 0.1% SDS, and 20 μg/ml
aprotinin) containing protease inhibitors (Complete Mini;
Roche Diagnostics).
Equal amounts of proteins from cell lysates (40 μg/lane)
were separated on NuPAGE 4-12% SDS-polyacrylamide
gels (Invitrogen) under denaturing conditions and transferred
onto nitrocellulose sheets (Hybond, GE Heathcare, Orsay,
France). Non-specific binding sites were blocked for 2 h with
5% non-fat dry milk in TBS containing 0.1% Tween-20.
After overnight incubation at 4˚C with anti-Fas rabbit poly-
clonal Ab (clone C20, Santa Cruz,) and anti-Fas mAb (clone
B10, Santa Cruz) (1/200 dilution) (both directed against
intracellular part of the receptor), membranes were incubated
with horseradish peroxidase (HRP)-conjugated Abs to mouse
or rabbit Ig (1/2000 dilution, DakoCytomation) for 60 min at
room temperature and revealed by chemiluminescence (ECL
reagent, Amersham Life Science, Inc., Buckinghamshire,
UK). Protein loading control was performed with rabbit
anti-GAPDH Ab (Santa Cruz Biotech). Western blots were
scanned using a bio-imaging system (Genesnap, Syngene,
Cambridge, UK).
Statistical analysis. Mean and standard errors (SEM) were
evaluated in three independent experiments. Statistical analysis
was carried out by ANOVA test using Statview (Ver. 5.0). A
p<0.05 (Fisher's PLSD test) was considered as significance.
Results
Characterization of U-87 MG cells. U-87 MG cell line is a
heterogeneous model which contains two cell-types: adherent
cells and small sphere cells forming aggregates (Fig. 1A). 
To characterize the U-87 MG cell line we used Abs
recognizing three different markers: GFAP (an astrocytic cell
marker), vimentin (a weakly differentiated cells marker) (29)
and CD133 (a stem cell marker) (30).
The majority of U-87 MG cells were stained with anti-
GFAP Ab (Fig. 1B); this result was confirmed by flow
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cytometry (Fig. 1F). The anti-vimentin staining demonstrated
that all cells were positive (Fig. 1C and G). Moreover, the
strongest intensity of vimentin staining seemed to be in small
sphere cells (Fig. 1C) and in cells present in aggregates
(Fig. 1D). Finally, by using CD133 marker, we detected
some CD133+ cells in aggregates (Fig. 1E), whereas these cells
were not detected by flow cytometry in total cell population
(Fig. 1H).
Fas-induced apoptosis in total U-87 MG cells. To define the
potential apoptotic functions of Fas receptor in glioblastoma,
apoptosis induced through the Fas pathway was evaluated in
U-87 MG cells, expressing Fas receptor as assessed by flow
cytometry analyses, by using antibodies directed either against
intracellular or extra-cellular part of Fas receptor (Fig. 2A
and B). 
After a 48-h culture, Fas activation was performed by a
24-h incubation of cells with an agonistic anti-Fas mAb
(7C11 - 40 ng/ml). Apoptosis was significantly induced
through Fas activation as detected by two methods. Indeed,
the measurement of soluble nucleosomes by ELISA showed
an increase of apoptotic ratio of cells incubated with anti-Fas
mAb (Fig. 2C) in comparison to cells cultured in basal
conditions (p=0.0059). These results were confirmed by flow
cytometric analysis showing the percentage of apoptotic
cells, only labelled by annexin-V (Fig. 2D represents one of
the three independent experiments). However, this method
showed that only a small percentage (18.43%) of cells of
the total population underwent to apoptosis in presence of
agonistic anti-Fas mAb, since 9.21% where stained in basal
conditions (p=0.008). Interestingly, this second method was
able to distinct a cell subpopulation sensitive to Fas-induced
BERTRAND et al:  FAS RECEPTOR AND GLIOMA STEM CELLS720
Figure 1. Characterization of U-87MG cell line. Cells in cultures (A) analyzed by microscopy and immunofluorescence with anti-GFAP (B), anti-vimentin
(C and D) and anti-CD133 (E) antibodies. Flow cytometry analysis of cells using same antibodies: anti-GFAP (F), anti-vimentin (G) and anti-CD133 (H); a
representative result of three independent experiments (isotypic control superimposed in gray). (Magnification: A, x200; B-E, x400).
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apoptosis, among the prominent other one resistant to Fas-
activated apoptosis. Therefore, the following results focused:
i) on the isolation of these two cell populations and ii) on
their apoptotic response through Fas activation pathway. 
Distinct cell populations identified by SdFFF elution. To isolate
and study these two subpopulations, we used an innovative
tool called Sedimentation field flow fractionation (SdFFF).
Fig. 3 displayed a representative fractogram of U-87 MG
cells. The first part of fractogram corresponded to the void
volume peak (Robs ≈ 1, retention ratio Robs = void time versus
retention time = t0/tR) (31) while the second and broader part,
corresponded to the cell elution profile. 
Elution conditions have been experimentally determined
to allow separation of larger cells from void volume peak,
reducing selective cells subpopulation lost. Then, a Robs value
was specifically measured for the more retained cells corres-
ponding to the last fraction and smaller cells (Fig. 3). Robs
F3 = 0.351±0.021 (n>6). As previously described (32,33), the
absolute Robs value particularly depends on culture conditions,
thus for U-87 MG cells the number of cell passages which
should range from 2 to 8. At constant flow rate (0.80 ml/min),
according to the ‘Hyperlayer’ elution mode description
(31,33-39), the Robs value for F3 is field dependant: Robs =
0.366±0.012 (n=3) at 20.00 g. By using the following
equation (40):
6s
R = –– (1)
ˆ
in which R is the retention ratio, ˆ is the channel thickness
(175 μm), and s the distance from the center of the focused
zone to the channel wall (40), we calculated the approximate
average cell elevation (s) using Robs values: s = 10.24 μm.
The mean cell diameter for F3 was 12.74±0.10 μm (n=3,
Coulter Counter®). Thus, radii of last eluted cells were less
than the approximate average cell elevation value: r = 6.37
< s =10.24 μm. Finally, after total cell elution, when the
external field was turned off (mean external field = 0.00 g,
end of rotating, ER) (Fig. 3), we observed a residual signal
(RP, Fig. 3) corresponding to the reversible particle release
from the accumulation wall. Four cell fractions were collected:
i) the total peak fraction (TP) which corresponded to the total
U-87 MG eluted population; and ii) peak fractions 1, 2 and 3
(PFn) which were time-dependent collected fractions of
retained cells (Fig. 3).
Morphological observations. After SdFFF elution cells were
cultured for 4 h and observed by optical microscopy. Fig. 4A
show that TP contained two cell types: adherent cells and
small sphere cells. PF1 was composed by a majority of
adherent cells (Fig. 4B), PF2 was a mix between the two
cells type (Fig. 4C) whereas small sphere cells were observed
in PF3 (Fig. 4D). These different observations demonstrated
that SdFFF could separate two cell types: large adherent cells
in PF1 and small sphere cells in PF3. Moreover, size and
density of the four fractions studied by flow cytometry (Fig. 5)
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Figure 2. Fas-induced apoptosis in whole U-87MG cell line. Expression of
Fas intracellular (A) and extracellular (B) domains, by flow cytometric
analysis. Apoptosis induced by a 24-h exposure to anti-Fas agonistic mono-
clonal antibody (7C11) compared to basal apoptosis (control) evaluated
either by ELISA measurement of cytoplasmic release of nucleosomes
(apoptotic index) (C) (*significant p-value) or by flow cytometry of annexin-V
staining (D), a representive result of three independent experiments. 
Figure 3. Representative fractogram of U-87 MG cell sorting by Sd FFF.
Eluted fractions of U-87 MG cells: TP, total peak; and PF, peak fractions.
For cell sorting: 4 fractions of cell sub-populations were collected: TP (2 min
15 sec to 8 min 00 sec) representative of the whole cell population and PF1
(2 min 15 sec to 3 min 50 sec), PF2 (4 min 00 sec to 6 min 00 sec) and PF3
(6 min 10 sec to 8 min 00 sec). Elution conditions were: flow injection of
100 μl of U-87 MG cell suspension (2.5x106 cells/ml); flow rate, 0.80 ml/min;
mobile phase, sterile PBS, pH 7.4; external multi-gravitational field strength,
24.50±0.05 g; spectrophotometer detection at Ï = 254 nm. ER, end of
channel rotation. RP, release peak of reversible cell-accumulation wall sticking.
Successive SdFFF cumulative fraction collections were performed: 8-10 to
obtain a sufficient quantity of cells for next experiments.
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showed that PF3 was enriched with small cells, confirming
optical microscopic observations.
Characterization of SdFFF fractions by flow cytometry. Three
markers, N-CAM, vimentin and CD133 have been used for
characterization. First, N-CAM was used to characterize
the adherent cells in glioma. Global expression of N-CAM,
observed in the TP revealed that 56.6% of cells were N-CAM+
(Fig. 6A). Furthermore, PF1 and PF2, the two enriched-
adherent cell fractions, contained 74 and 78.6% N-CAM+
cells, respectively (Fig. 6B and C), whereas in PF3, 59.9%
N-CAM+ cells were detected (Fig. 6D).
Then, vimentin, expressed in cells in proliferation and
differentiation and generally characteristic of the weakly
differentiated cells (29) was assessed. The total expression of
vimentin, analyzed in the TP (Fig. 7A) was similar to those
in PF1 and PF2 cells (Fig. 7B and C) while vimentin expression
was more strongly expressed in PF3 (Fig. 7D). These results
demonstrated different vimentin expression levels between
the three fractions with highest level in PF3, containing the
most immature cells as hypothesized by morphological
features.
Indeed, we analyzed this cell fraction with anti-CD133
Ab, CD133 being described as a stem cell marker (30).
CD133 staining was reported to be associated to brain stem
tumor-initiating cells, that reconstitute the original tumor
in vivo and after transplantation (4). By flow cytometry, CD133
expression was detected in a small percentage (11.8%) of
total cell line and of the TP (Fig. 8A). Interestingly, PF3 was
strongly enriched with 72% CD133+-expressing cells (Fig. 8D),
in contrast to other fractions, PF1 and PF2, containing 12.95
and 25% CD133+ cells, respectively (Fig. 8B and C). Together,
these markers revealed that the F3 cell subpopulation contained
cells expressing immature (vimentin+) and stem cell markers
(CD133+), in contrast to F1 cell sub-population, containing
most mature (N-CAM+) cells. 
U-87 MG cells cultured in serum-free medium. To obtain
CD133+-enriched cells, U-87 MG cells were cultured in
FCS-free medium (23). Contrasting with the two different
cell types detected in U-87 MG cell line cultured with
FCS-containing medium (adherent cells and cells forming
aggregates) (Fig. 9A), U-87 MG cells cultured in serum-free
medium displayed neurosphere-like aggregates (Fig. 9B and C).
Study of cell size determined by flow cytometry showed that
cells in FCS-free medium (Fig. 9E) were smaller than cells
cultured in normal (FCS-containing) medium (Fig. 9D). In
these conditions, the staining of cells with anti-CD133 Ab
demonstrated that 34.38% cells were CD133+ (Fig. 9F and G)
a percentage significantly higher than in FCS-containing
medium (p=0.0074). Therefore, U-87 MG cells cultured in
FCS-free medium formed neurospheres containing CD133+
stem cells.
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Figure 4. Morphological aspects of cells in culture. After a 4-h subculture,
cell fractions were observed by optical microscopy. TP (A) contained two
cell types: adherent and small sphere cells. Most of adherent cells were
localized in F1 (B) and F2 (C) whereas small sphere cells were observed in
F3 (D). Magnification x400.
Figure 5. Study of cell size and density after SdFFF elution. The study of
cell size and density in fractions TP (A), F1 (B), F2 (C) and F3 (D), by flow
cytometry showed that smallest cells were contained in F3.
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Oligomeric aggregate Fas receptor detected in the eluted
fraction PF1 (most mature cells) but not in PF3 (immature
cells). Fas receptor was expressed in the different cell sorting
fractions as shown by Western blotting (Fig. 10A). However,
some differences of Fas protein oligomerization were iden-
tified among the eluted cell fractions. Whereas Fas monomer
(45 kDa) was detected in the 3 fractions and in the whole cell
population (TP), a higher molecular weight protein of 120 kDa
was the predominant form detected in the whole cell and PF1
protein lysates. In contrast, PF3 proteins, containing mostly
the monomeric form. This high molecular weight of Fas
receptor was detected with an antibody directed against the
intracellular part of the receptor, available to detect the
aggregated Fas receptor (14), described as the effective form
of pre-associated Fas receptor, able to induce apoptosis (10). 
Different sensitivity to Fas-induced apoptosis depending on cell
maturation. The apoptotic response to a 24-h incubation with
agonistic anti-Fas mAb (7C11-40 ng/ml) was different between
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Figure 6. N-CAM expression in eluted fractions. N-CAM expression was
measured by flow cytometry after SdFFF elution. N-CAM-expressing cells
were evaluated in TP (A) in comparison to isotypic control (ISO). N-CAM+
cell enrichment was detected in F1 (B) and F2 (C) but not in F3 (D) (compared
to N-CAM expression in TP, superimposed in grey). A representative
experiment of three independent tests. 
Figure 8. CD133 expression in eluted fractions. After the SdFFF elution,
flow cytometry analysis of CD133 expression, detected in whole cell
population (TP) compared to isotypic control (ISO) (A) was similar to those
in F1 (B) and F2 (C) sub-populations (compared to TP staining super-
imposed in black). In contrast, F3 sub-population is enriched in CD133+
cells (D, compared to TP staining in black). A representative result of three
independent experiments. 
Figure 7. Vimentin expression in eluted fractions. After SdFFF elution,
vimentin expression, evaluated by flow cytometry in whole cell population,
represented in TP (A, compared to isotypic control in grey) is super-
imposable to cell expression in F1 and F2, while the highest vimentin-
expressing cells were detected in F3 (D). A representative result of three
independent experiments, F1, F2 and F3 vimentin expression was compared
to those of total cells (TP, superimposed in black).
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the eluted cell fractions as assessed by annexin-V staining
(Fig. 10B). Indeed, a significant difference was detected
between the 3 SdFFF fractions: most mature cells (PF1
sub-population) exhibited the highest apoptotic rate (38%),
whereas, sensitivity to apoptosis of immature cells (PF3
sub-population), was significantly lower (25%) (p=0.0314,
Fig. 10B). An intermediate stage of sensitivity to apoptosis
(30%) was detected in eluted cells from intermediate fraction,
PF2, which was similar to those obtained in whole cells,
obtained after cell sorting (TP; 32%). In contrast, basal
apoptosis (without Fas activation) of total cells (contained in
PT) after cell sorting by SdFFF was lower, ~20% (data not
shown). 
Likewise, stem cells forming neurosphere-like, obtained
in serum-free medium, were insensitive to a 24-h incubation
with the agonistic anti-Fas Ab (7C11 - 40 ng/ml) (17.33±2.14%
of apoptotic cells). Apoptotic ratios were similar to those
obtained in cells cultured in basal conditions (15.36±1.42%,
p>0.05) (Fig. 10C). These results demonstrated that cells
present in neurospheres were resistant to Fas-induced apoptosis
which assessed results obtained in SdFFF eluted cells.
Discussion
The aim of this study was to determine the sensitivity dif-
ference of human glioma cells to Fas-induced apoptosis
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Figure 9. U-87MG cells cultured in serum-free medium. Whereas two different cell types were detected in U-87 MG cell line cultured with FCS-containing
medium (adherent cells and cells forming aggregates) (A), cultures in serum-free medium contained cells aggregated in neurospheres (B and C). Cell size
determined by flow cytometry showed that cells in free medium (E) were smaller than those cultured in FCS-containing medium (D). The percentage of
CD133-expressing cells was significantly higher in cultures maintained in serum-free (neurosphere-like) than cells cultured in FCS-contained medium (F)
(*significant p-value, three independent experiments). A representative result of CD133 expression (G) in serum-free cultures, compared to normal FCS-
containing medium (superimposed in grey). 
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among the maturation stage of cells contained in the human
U-87 MG line. Such objective was supported by the hypothesis
that resistance of gliomas to treatment could be due to some
difference in sensitivity to apoptosis induction among cells
contained in the U-87 MG glioma cell line. The induction of
apoptosis through the death receptor, Fas, by an agonistic
mAb (7C11) was evaluated in the whole cell population
showing that only a small fraction of total population was
sensitive to Fas-activated apoptosis. In order to separate
sensitive and resistant cells to Fas-induced apoptosis, we have
studied the apoptotic response in different fractions obtained
after SdFFF U-87 MG cell sorting, a non-invasive and tagless
method for cell separation that was previously used in different
application fields of oncology (27,32,33,41-43). Different
aspects have been evaluated including: i) monitoring of the
apoptosis or differentiation induction (32,33,42,43); ii) cell
sorting of specific subpopulations [pre-apoptotic (33),
differentiated cells (32)]; iii) kinetics of apoptosis (27).
SdFFF was also used to sort specific phenotypes from complex
cancer cell populations such as neuroblastomas (26), or to
sort immature cancer cells (22), two applications which can
be directly used in this study.
As previously described (22,27,33,39,44,45), cell
species are eluted under the Hyperlayer model, a size/density
dependent cell elution mode (31,33-39), which predicts
that large and weaker cells are focused in faster streamlines
to be eluted first. Hyperlayer elution mode allowed, by
limiting cell-accumulation wall interactions, a cell elution
which: i) respected repeatability, reproducibility and recovery;
ii) respected cell functional integrity; iii) provided high levels
of short and long-term viability (no apoptosis induction);
iv) respected the maturation and differentiation stages; and
finally; v) enhanced better sub-population sorting and charac-
terization (20,22,26,27). 
U-87 MG cell line appeared as a heterogeneous population
(Fig. 4), leading, as for neuroblastoma cell line (26), to complex
fractograms (Fig. 3) in contrast to many other cell lines
(22,27,42,43). According to results concerning: i) the particle
elution away from the accumulation wall (s>r); ii) field
dependence of the Robs value; and iii) the limited interactions
between cells and accumulation wall leading to low reversible
cellular release (RP, Fig. 3); we can suppose that U-87 MG
cells were eluted under Hyperlayer elution mode as it has
been demonstrated for other cell models (22,26,27,44,45). 
However, from a biological point of view, we did not know
if cell sorting of the different U-87 MG sub-populations of
interest was achieved. Four cell fractions were collected: the
total peak fraction (TP) which corresponded to the total U-87
MG population eluted, used as control of whole cells; and
three peak fractions 1, 2 and 3 (PFn) which are the time-
dependent collected fractions of the retained peak profile.
Cell culture, morphological observation, specific antigen
expression and apoptosis analysis were performed in each
fraction in order to characterize these different sub-populations
and to determine their respective apoptosis sensitivities to
Fas activation.
A previous study on the neuroblastoma cell line IMR-32
(26) showed that SdFFF could separate two phenotypes from
the same cell lineage: the first N-phenotype forming a pool
of quiescent undifferentiated cells and the second able to
proliferate and to give rise also adherent S-type cells (26). In
this way, we demonstrated that SdFFF could separate two
phenotypes from U-87 MG: large adherent cells in PF1 and
small sphere cells in PF3. Moreover, the characterization
by flow cytometry of these two sub-populations (PF1 and
PF3) determined that cells eluted in PF3 were the most
undifferentiated, containing the highest vimentin labeling
(29). On the other hand, the neural stem cells marker CD133
(30) allowed us to demonstrate the SdFFF capacity to
isolate cancer neural stem cells. Likewise, SdFFF analysis
could separate two distinct cell phenotypes: i) in PF1: most
differentiated large adherent cells, CD133-; and ii) in PF3:
most undifferentiated small sphere cells, CD133+. Therefore,
Fas activation was studied on these two phenotypes PF1 and
PF3. First, we have shown that no significant difference
between basal apoptotic rates of the different fractions (data
not shown) was observed. However, we have calculated a
higher basal apoptotic rate (20%) after SdFFF elution than
calculated in U-87 MG cell line, possibly due to the use of
high external field for separating larger cells from void
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Figure 10. Comparative effect of Fas activation depending on maturation
stage of cells in Sd FFF isolated fractions and in glioma neural stem cells.
Western blotting of U-87 MG cell proteins with anti-Fas mAb directed
against intracellular part of Fas receptor (A), detection of monomeric form
of Fas (45 kDa) in the three eluted cell fractions (F1, F2, F3) as in the whole
population. The oligomeric aggregates of Fas receptor (120 kDa) were not
detected in F3. GAPDH, detected by specific Ab, is the control of protein
loading. Apoptosis induced by agonistic anti-Fas mAb (7C11) studied by
annexin-V staining revealed that apoptosis was significantly (*) higher in F1
cells than in F3 (B). Cells cultured in serum-free medium were resistant to
7C11-induced apoptosis (C) as assessed by similar apoptotic percentage in
cells maintained in serum-free medium without Fas activation (control). 
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volume. Nevertheless, the study of Fas-activating apoptosis
in SdFFF eluted fractions, showed a significant difference
between PF1 and PF3. Indeed, cells sorted in PF1 (large
adherent cells, and CD133-) seem to be the most sensitive to
the apoptosis induced by Fas receptor activation while cells in
PF3 (small sphere cells, most undifferentiated and CD133+)
are the most resistant to Fas-induced apoptosis. A previous
study demonstrated that CD133+ cells were responsible of
preservation and proliferation of the tumor in glioma (3).
Therefore, this tumor cell sub-population could be implicated
in the resistance of glioblastoma to Fas-induced apoptosis.
The culture in defined serum-free medium was described to
be a selective growth medium of enriching neural stem cells
in cultures from normal brain tissues (46) as brain tumor (23).
In comparison, SdFFF cell sorting also performed the isolation
of cancer stem cells, expressing CD133+. Furthermore, cells
obtained by this selective culture method exhibited resistance
to apoptosis, similar to those sorted in PF3. Therefore, we
could assess that SdFFF is able to quickly separate immature
cancer stem cells, expressing CD133, from most differentiated
(CD133-) and adherent, N-CAM-expressing cells. N-CAM
expression in gliomas was described to enhance adhesion and
reduce cell invasion and tumor growth (47) and is expressed
by normal differentiated astrocytes (48). These adherent
cells, eluted in PF1, contained oligomeric aggregates of Fas
receptor, the initial signalling form of Fas (10) and were
sensitive to apoptosis through Fas pathway. In contrast CD133+
PF3 cells contained mostly the monomeric form of Fas
receptor and were resistant to apoptosis induced through Fas
activation. 
As glioblastomas were described to be due to abnormal
differentiation of neural stem cells belonging to the sub-
ventricular zone (3), it seems of first importance to focus
research on new therapeutic pathways to eradicate cancer
stem cells, isolated from tumor patients. The conditions for
inducing differentiation of these immature cells need to be
further defined in order to re-establish the response of
gliomas to chemotherapy.
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